Keyphrases
Resistance Mechanisms
100%
Multiresistant
100%
Multidrug-resistant Pathogens
100%
Gram-negative Pathogens
100%
Clinical Problems
50%
Infection Rate
50%
Bacterial Infection
50%
Gram-negative
50%
Enterobacteriaceae
50%
Pseudomonas Aeruginosa (P. aeruginosa)
50%
Control Challenges
50%
New Antimicrobials
50%
Prevalence Risk
50%
Klebsiella Pneumoniae (K. pneumoniae)
50%
Gram-negative Bacteria
50%
Infection Control
50%
Extended-spectrum-lactamase
50%
Transfer Mechanism
50%
Acinetobacter Baumannii (A. baumannii)
50%
Rapid Spread
50%
Global Infection
50%
Gram-negative Bacterial Infections
50%
Carbapenem-resistant Enterobacteriaceae
50%
Non-fermenters
50%
Antibiotic Drug Development
50%
Pharmacology, Toxicology and Pharmaceutical Science
Infectious Agent
100%
Prevalence
66%
Infection
66%
Drug Development
33%
Bacterial Infection
33%
Antibiotic Agent
33%
Pseudomonas aeruginosa
33%
Enterobacteriaceae
33%
Gram Negative Bacterium
33%
Klebsiella pneumoniae
33%
Penicillinase
33%
Infection Rate
33%
Gram Negative Infection
33%
Carbapenem Resistant Enterobacteriaceae
33%
Acinetobacter Baumannii
33%
Antimicrobial Agent
33%
Medicine and Dentistry
Pathogen
100%
Prevalence
66%
Infection
33%
Bacterial Infection
33%
Pseudomonas aeruginosa
33%
Klebsiella pneumoniae
33%
Gram-Negative Bacteria
33%
Penicillinase
33%
Enterobacteriaceae
33%
Acinetobacter Baumannii
33%
Infection Rate
33%
Gram-Negative Bacterial Infection
33%
Carbapenem-Resistant Enterobacteriaceae
33%
Infection Control
33%
Antimicrobial Agent
33%
Biochemistry, Genetics and Molecular Biology
Infectious Agent
100%
Prevalence
66%
Enterobacteriaceae
33%
Pseudomonas aeruginosa
33%
Infection Rate
33%
Gram Negative Bacterium
33%
Klebsiella pneumoniae
33%
Carbapenem-Resistant Enterobacteriaceae
33%
Acinetobacter Baumannii
33%